Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations. - Wikidata - wikimedia - TriplyDB

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

http://www.wikidata.org/entity/Q37226360

about

Disease-related autoantibody profile in patients with systemic sclerosis.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

P2860

Q47685250-776ECE6A-0275-4D71-BB87-DF4477EEF667 Q52597638-1C14BFC8-2A69-4219-A080-AF102570A5D8

P2860

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

http://www.wikidata.org/entity/Q37226360

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@en

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@nl

type

label

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@en

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@nl

prefLabel

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@en

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@nl

P1433

Q37226360-82C995BD-2755-41BC-8E12-393E0FE81E0D

P1476

Q37226360-DE1B3E6A-145F-43B4-B011-E02849BD07F3

P2093

Q37226360-02642629-26C5-4DFD-924D-96AC304DD9BA

Q37226360-06199C9A-C8A5-43EC-B560-D3ECC5E38724

Q37226360-11F95E98-4882-4CCC-9D5B-10DFF9ABD513

Q37226360-2641A742-C5AF-48C7-A3C3-D5409AF39E6B

Q37226360-3B62CE34-AEEA-4F35-8CF1-7A42E9328F00

Q37226360-7C7BFEEA-A583-4465-A681-15693628E19E

Q37226360-9A7A04AA-9296-49F4-982E-0B40AF5B4DBD

Q37226360-B2BBB119-F554-41BC-AD68-5465B23ADA83

Q37226360-B91ED4ED-94F7-4945-90D2-412611DC15D1

Q37226360-D8CF113F-F2DB-4793-B48F-0803276D59EF

P2860

Q37226360-06B648B7-CB00-4C74-851D-BEC53A67A683

Q37226360-09A11E41-0CD8-426A-B209-0B3D0AFB2DFD

Q37226360-15A03958-4884-4442-BCAD-275E20BA6A89

Q37226360-193DAC07-93F7-42C3-9135-E57A968547E9

Q37226360-1BA6A96D-CA88-43DF-825E-86B0D0659197

Q37226360-1BAF3B94-F887-441C-A403-37B0BBA3B71B

Q37226360-1DF16113-A45B-4063-BEAE-8F5EB318DD12

Q37226360-258329CB-F160-4D03-983F-CF9B3F77C448

Q37226360-2715E042-9E46-4CE8-B687-2A11B8EA6480

Q37226360-2A8852AB-7BFC-4A85-B63E-8C09CAAF25C7

P304

Q37226360-322D6476-16C4-4DF1-85D2-A7C3724D08D5

P31

Q37226360-4D198AF1-B75E-4AA2-A83F-BE165E941B31

P356

Q37226360-F02583A0-2797-40F4-A708-A7CFE1ECE662

P407

Q37226360-228889E8-E960-4070-AF95-F73262770630

P433

Q37226360-CA2AF7C2-460D-48D3-8E9B-5B22AE182518

P478

Q37226360-AD8E6BC9-7768-4369-9D87-B3FB86EB262D

P50

Q37226360-8E82F3EB-A5A2-438E-BD63-ACEE8A25F535

P577

Q37226360-384E9CA9-6954-4829-B73A-8056EF5C557E

P698

Q37226360-9CCD05C3-6AD9-435A-8FA4-01184DFABDFF

P932

Q37226360-756D1021-77D3-4C52-952C-EE6BE6A1D9AE

P356

MD.0000000000004713

P1433

P1476

Single-specificity anti-Ku ant ...... bjects: clinical associations.

@en

P2093

Canadian Scleroderma Research ...... oderma Outcome Study (GENISOS)

http://www.w3.org/2001/XMLSchema#string

J Walker

http://www.w3.org/2001/XMLSchema#string

M Baron

http://www.w3.org/2001/XMLSchema#string

M D Mayes

http://www.w3.org/2001/XMLSchema#string

M Hudson

http://www.w3.org/2001/XMLSchema#string

M Nikpour

http://www.w3.org/2001/XMLSchema#string

M Wang

http://www.w3.org/2001/XMLSchema#string

S Assassi

http://www.w3.org/2001/XMLSchema#string

S Hoa

http://www.w3.org/2001/XMLSchema#string

S Proudman

http://www.w3.org/2001/XMLSchema#string

P2860

Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing.

Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination

Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization

The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen

2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.

Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura.

Clinical and serological associations of anti-Ku antibody.

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

P304

e4713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000004713

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Marvin J Fritzler

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27583908

http://www.w3.org/2001/XMLSchema#string

P932

5008592

http://www.w3.org/2001/XMLSchema#string